EPISODE · Aug 10, 2023 · 14 MIN
In conversation with... Marc Rothenberg
from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet
Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases.
NOW PLAYING
In conversation with... Marc Rothenberg
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m